Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Adagene Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 16 | 19 | +3 |
| Shares | 5.94M | 8.79M | +2.85M (+48.0%) |
| Value | $80.5M | $126.6M | +$46.1M (+57.2%) |
New holders (6)
Institutions that held Adagene Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SC China Holding Ltd | 1,343,364 | $19.3M | 1.73% |
| FMR LLC | 1,254,913 | $18.0M | 0.00% |
| CloudAlpha Capital Management Limited/Hong Kong | 300,000 | $4.31M | 3.10% |
| E Fund Management Co., Ltd. | 58,670 | $851.0K | 0.04% |
| ExodusPoint Capital Management, LP | 32,243 | $463.0K | 0.01% |
| Citigroup Inc | 654 | $9.00K | 0.00% |
Sold out (3)
Institutions that held Adagene Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Trellus Management Company, LLC | 55,000 | $746.0K |
| Alyeska Investment Group, L.P. | 40,000 | $542.0K |
| Millennium Management LLC | 21,953 | $298.0K |